Chapter-1: 1.1 Antibiotics
Chapter-1: 1.1 Antibiotics
Introduction
1.1 Antibiotics
Antibiotics or antibacterials are a type of antimicrobial used in the treatment and prevention of
bacterial infection.They may either kill or inhibit the growth of bacteria. Several antibiotics are also
effective against fungi and protozoans, and some are toxic to humans and animals, even when given
in therapeutic dosage. Antibiotics are not effective against viruses such as the common cold or
influenza, and may be harmful when taken inappropriately. Antibiotics revolutionized medicine in
the 20th century, and have together with vaccination led to the near eradication of diseases such as
tuberculosis in the developed world. Their effectiveness and easy access led to overuse, especially in
live-stock raising, prompting bacteria to develop resistance. This has led to widespread problems
with antimicrobial and antibiotic resistance, so much as to prompt the World Health Organization to
classify antimicrobial resistance as a "serious threat [that] is no longer a prediction for the future, it
is happening right now in every region of the world and has the potential to affect anyone, of any
age, in any country".The era of antibacterial chemotherapy began with the discovery of
arsphenamine, first synthesized by Alfred Bertheim and Paul Ehrlich in 1907, used to treat syphilis.
The first systemically active antibiotic, prontosil was discovered in 1933 by Gerhard Domagk, for
which he was awarded the 1939 Nobel Prize. Sometimes the term antibiotic is used to refer to any
substance used against microbes, synonymous to antimicrobial. Some sources distinguish between
antibacterial and antibiotic; antibacterials used in soaps and cleaners etc., but not as medicine. This
article treats the terms as synonymous and according to the most widespread definition of
antibiotics being a substance used against bacteria.
Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical
structure, or spectrum of activity.
1.2.1.1 Bactericidal
Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane
(polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and
sulfonamides) have bactericidal activities.
1.2.1.2 Bacteriostatic
Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually
bacteriostatic (with the exception of bactericidal aminoglycosides)
1.2.2.1 Narrow-spectrum
1.2.2.2 Broad-spectrum
1928: A. Fleming discovered that his cultures of staphylococci was contaminated with a fungus, and
that the colonies of staphylococci immediately surrounding the fungus had been destroyed, whereas
other staphylococci colonies farther away were normal. This fungi was the Penicillium notatum which
produced a bactericidal agent. The penicillins are the oldest of the clinical antibiotics, but are still the
most widely used. The first of the many penicillins to be employed on a significant scale was
penicillin G (benzylpenicillin), obtained from the fungus Penicillium chrysogenum by fermentation in
a medium containing corn-steep liquor. The α-aminoadipyl side-chain of isopenicillin N is removed
and replaced by another acid according to its availability from the fermentation medium. Several other
penicillins are accessible by supplying different acids.
1.3.2 Aminoglycosides
OHC OH H2N
NH2
O N OH
H2N N O O O H2N
NH H2N NH2
HO O HO HO NH2 OH
O O HO O O
OH O
H2N N N O O NH2
OH OH
OH OH OH OH NH2 NH2 OH
NH2
Fig1.2: Aminoglycosides
The aminoglycosides form an important group of antibiotic agents and are immediately recognizable
as modified carbohydrate molecules. Typically, they have two or three uncommon sugars, mainly
aminosugars, attached through glycoside linkages to an aminocyclitol, i.e. an amino-substituted
cyclohexane system, which also has carbohydrate origins. The aminoglycoside antibiotics have a
wide spectrum of activity, includingactivity against some Gram-positive and many Gram-negative
bacteria. They must be administered by injection. The widespread use of aminoglycoside antibiotics is
limited by their nephrotoxicity, which results in impaired kidney function, and by their ototoxicity,
which is a serious side-effect and can lead to irreversible loss of hearing. The aminoglycoside
antibiotics interfere with protein biosynthesis.
The cyclosporins are a group of cyclic peptides produced by fungi such as Cylindrocarpon lucidum
and Tolypocladium inflatum. These agents show a narrow range of antifungal activity , but high levels
of immunosuppressive and anti-inflammatory activities. It is now widely exploited in organ and tissue
transplant surgery to prevent rejection following bone-marrow, kidney, liver, pancreas, lung, and heart
transplants. It has revolutionized organ transplant surgery, substantially increasing survival rates in
transplant patients.
O HO
O
O N HN
N N
NH O
O
N O
O N O O
H
N N
N N
H
O O
Fig1.3: Cyclosporin A
1.3.4.1 Bleomycin
NH2
H2N O
Fig1.4: Bleomycin
1.3.4.2 Vancomycin
NH
HO
O NH2
O NH O
N
H
Fig1.5: Vancomycin
The macrolide antibiotics are macrocyclic lactones with a ring size typically 12–16 atoms, and with
extensive branching through methyl substituents. Polyene macrolides are larger in the range 26–38
atoms. The largest natural macrolide structure discovered has a 66-membered ring. Two or more
sugar units are attached through glycoside linkages; these sugars tend to be unusual 6-deoxy
structures often restricted to this class of compounds. Macrolides are protein synthesis inhibitors.
OH O O
HO
O O O
O
O
OH OH
N
Fig1.6: Erythromycin
Most polyene macrolides have antifungal properties, but not antibacterial activity. The
macrolide ring size ranges from 26 to 38 atoms, and this also accommodates a conjugated
polyene of up to seven E double bonds.
1.3.6 Amphotericin
Amphotericin is active against most fungi and yeasts, but it is not absorbed from the gut, so
oral administration is
OH
NH2
O
OH
OO
HO
HO
O HO
OH
HO
O
OH OH OH OH O
Fig1.7: Amphotericin
The tetracyclines are a group of broad-spectrum, orally active antibiotics produced by species
of Streptomyces, and several natural and semi synthetic members are used clinically. Their
antimicrobial activity arises by inhibition of protein synthesis. Although the tetracycline
antibiotics have a broad spectrum of activity spanning Gram-negative and Gram-positive
bacteria, their value has decreased as bacterial resistance has developed in pathogens such as
Pneumococcus, Staphylococcus, Streptococcus, and E. coli.
Cl OH N
OH
NH2
OH
OH O OH O O
Fig1.8: Chlortetracycline
A number of anthracycline antibiotics, e.g. doxorubicin (one of the most successful and
widely used antitumour drugs) from Streptomyces peuceticus and daunorubicin from
Streptomyces coeruleorubicus, have structurally similar tetracyclic skeletons and would
appear to be related to the tetracyclines. However, anthraquinone derivatives are
intermediates in anthracycline biosynthesis, and the fourth ring is constructed later.
OH
O OH
OH
O
O O OH O NH2
O
OH
Fig1.9: Doxorubicin
Late 1800s
The search for antibiotics began in the late 1800s, with the growing acceptance of the germ theory of
disease , a theory which linked bacteria and other microbes to the causation of a variety of ailments.
As a result, scientists began to devote time to searching for drugs that would kill these disease-causing
bacteria.
1871
The surgeon Joseph Lister, began researching the phenomenon that urine contaminated with mold
would not allow the successful growth of bacteria.
1890s
German doctors, Rudolf Emmerich and Oscar Low were the first to make an effective medication that
they called pyocyanase from microbes. It was the first antibiotic to be used in hospitals. However, the
drug often did not work.
1928
Sir Alexander Fleming observed that colonies of the bacterium Staphylococcus aureus could be
destroyed by the mold Penicillium notatum, demonstrating antibacterial properties.
1935
Prontosil, the first sulfa drug, was discovered in 1935 by German chemist Gerhard Domagk (1895–
1964).
1942
The manufacturing process for Penicillin G Procaine was invented by Howard Florey (1898–1968)
and Ernst Chain (1906–1979). Penicillin could now be sold as a drug. Fleming, Florey, and Chain
shared the 1945 Nobel Prize for medicine for their work on penicillin.
1943
In 1943, American microbiologist Selman Waksman (1888–1973) made the drug streptomycin from
soil bacteria, the first of a new class of drugs called aminoglycosides. Streptomycin could treat
diseases like tuberculosis, however, the side effects were often too severe.
1955
Tetracycline was patented by Lloyd Conover, which became the most prescribed broad spectrum
antibiotic in the United States.
1957
Nystatin was patented and used to cure many disfiguring and disabling fungal infections.
The many modes of antibiotic action are shown schematically in the diagram below.
Antibiotic Mechanism
Pennicillin Inhibits transpeptidase enzymes. Activates lytic enzymes of cell wall. The
affected bacterium will eventually lyse because the unsupported cell wall
cannot withstand its growth.
Chloramphenicol Blocks formation of new peptide bonds during protein synthesis by binding to
the 50S subunit of the ribosome.
Erthromycin Binds the 50S subunit and blocks translocation of the new protein on the
ribosome, thus effectively halting synthesis.
Linezolid Binds rRNA to prevent translation initiation and thus protein synthesis.
Streptomycin Binds the 30S ribosomal subunit of the tuberculosis bacterium and prevents the
ribosome from forming the complex necessary to initiate protein translation.
Streptomycin is the first line of chemical defense against Mycobacterium
tuberculosis.
Tetracyclines Binds to the 30S subunit and blocks the addition of amino acids, producing
incomplete and probably nonfunctional proteins.
Dapsone Interferes with synthesis of folic acid, which is required for the synthesis of
purines and thymidine and for the synthesis of the amino acids methionine and
glycine.
Many bacterial strains now resist the effects of antibiotics that once could destroy them. Every
population of bacteria may have some individuals that are resistant. The proliferation of antibiotics
and careless use of the drugs have given some resistant bacteria the upper hand in the fight against
disease.
A patient who is prescribed a 10-day course of antibiotics, but who quits taking them after a couple of
days because the symptoms have subsided, leaves behind bacteria that resisted the antibiotic effect.
Growth of these bacteria may have slowed in the presence of the antibiotic, but the bacteria are not
completely wiped out. Some resistant bacteria may survive an even longer course of antibiotics if the
dosage of the drug is not high enough. Typically, after a complete, full-strength antibiotic course, so
few resistant bacteria remain that the body’s own immune system can handle them; however, a short
course may leave behind so many resistant bacteria that they proliferate. These resistant bacteria also
have a better chance to flourish because the other, weaker, bacteria have died. It’s the scenario for a
medical crisis.
Resistant bacteria have always been around and existed long before humans began using antibiotics
therapeutically. What is new in the world of resistance is how quickly new resistant strains arise. The
widespread use and misuse of antibiotics contribute to the problem. For the first time in decades,
people in the United States are dying of bacterial infections that cannot be treated.
Right after we began using penicillin, some Staphylococcus strains were identified as resistant
to it.
o Today, 80 percent of Staphylococcus strains do not respond to penicillin.
In the 1940s and early 1950s, streptomycin, chloramphenicol, and tetracycline were
discovered.
o By 1953, a strain of Shigella was found that resisted these antibiotics and
sulfanilamides.
o By the 1970s, resistant strains of gonorrhea arose.
The 1990s saw the development of true superbugs, bacteria that resist all known antibiotics.
o One antibiotic of last resort is Vancomycin, a powerful antibiotic that attacks bacteria
on many fronts.
o Now there are Enterococci strains that resist Vancomycin.
Multi-drug resistant tuberculosis strains have arisen.
o By the 1940s and 1950s, a single antibiotic, such as Streptomycin, no longer cured
tuberculosis, as it had in the past.
o Tuberculosis is the leading cause of death by infectious disease in the world.
Bacteria either have preexisting resistance to drugs, or they develop resistance. Human activity has
contributed greatly to the increase in resistant strains of bacteria. Often, when bacteria acquire
resistance to a certain drug from a particular class (e.g., the penicillins), the bacteria also acquire
resistance to all other drugs in that class.
1.12 Some of the many mechanisms of resistance are indicated schematically in the
following diagram:
The principles of Darwinian evolution act on bacteria with inherent resistance: those bacteria that
resist an antibiotic's effects are better suited to survive in an environment that contains the antibiotic.
In the case of inherent resistance and vertical evolution, the genes that confer resistance are found on
bacterial chromosomes and are transferred to the bacterial progeny every time the cell divides.
1.13.3 Conjugation
Bacteria have circles of DNA called plasmids that they can pass to other bacteria during
conjugation.
Plasmids, the key players in conjugation, are even referred to as resistance transfer factors.
This type of acquisition allows resistance to spread among a population of bacterial cells
much faster than simple mutation and vertical evolution would permit.
1.13.4 Transduction
1.13.5 Transformation
There are a number of ways enzymes have been used by bacteria to confer antibiotic resistance:
Resist b-lactam antibiotics through modifications in the genetic code for the proteins that bind
penicillin.
Genes for enzymes that can destroy or disable antibiotics are acquired or arise through
mutation. For example, a b-lactamase enzyme can destroy the b-lactam ring of penicillins
through hydrolysis, and without a b-lactam ring, penicillins are ineffective against the
bacteria.
For antibiotics that target DNA gyrase, the enzyme that unwinds DNA for replication, random
mutations in the bacterial DNA may alter the gyrase and make it unrecognizable to antibiotics while
still leaving it functional.
In the case of sulfonamides, which operate by mimicking PABA and competing for an enzyme that
synthesizes folic acid, an increase in the amount of PABA can outcompete the sulfonamide and render
it ineffective; or an alteration in the code for the enzyme itself can prevent its sulfonamide binding.
One particularly active way a bacterium may deal with an antibiotic is to pump it out, perhaps using
proteins encoded by acquired genes. For example, a strain of enterococcal bacteria can pump out
tetracycline. This type of pumping is called an “efflux phenomenon.”
Note: Bacteria without inherent antibiotic resistance can acquire—through conjugation, transduction,
or transformation—the genes that encode proteins that confer resistance .
Is an antibiotic necessary ?
What is the most appropriate antibiotic ?
What dose, frequency, route and duration ?
Is the treatment effective ?
1.16.3 Is an antibiotic necessary ?
Poultry farming is the raising of domesticated birds such as chickens, turkeys, ducks, and geese, for
the purpose of farming meat or eggs for food. Poultry are farmed in great numbers with chickens
being the most numerous.More than 50 billion chickens are raised annually as a source of food, for
both their meat and their eggs. [1] Chickens raised for eggs are usually called laying hens whilst
chickens raised for meat are often called broilers.
In total, the UK alone consumes over 29 million eggs per day. In the US, the national organization
overseeing poultry production is the Food and Drug Administration (FDA). In the UK, the national
organization is the Department for Environment, Food and Rural Affairs (Defra).
Both the government and a variety of non-governmental organization(NGO) are actively promoting
poultry development at all level.The Bangladesh Rural Advancement Commission (BRAC),the
largest,shows in its annual report that more than 70% of rural households are involved in poultry
keeping.But they face serious constraints,as the mortality rate of poultry is said to be as high as
25%,due to a combination of improper feeding practices, ignorance of management,poor distribution
of vaccine & misuse of medication.